Gentech Laboratories Comprehensive Company Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 07-07-2024
- Paid Up Capital ₹ 0.60 Cr
as on 07-07-2024
- Company Age 43 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 0.95 Cr
as on 07-07-2024
- Satisfied Charges ₹ 21.76 Cr
as on 07-07-2024
About Gentech Laboratories
The Corporate was formerly known as Gentech Laboratories Ltd. The Company is engaged in the Finance And Insurance Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 0.60 Cr.
The company currently has active open charges totaling ₹9.48 M. The company has closed loans amounting to ₹21.76 Cr, as per Ministry of Corporate Affairs (MCA) records.
Rajesh Gandhi, Chandrakant Gandhi, Manharlal Shah, and Two other members serve as directors at the Company.
- CIN/LLPIN
U85195MH1981PTC024412
- Company No.
024412
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
15 May 1981
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Gentech Laboratories?
Board Members(5)
Financial Performance and Corporate Structure Insights of Gentech Laboratories.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Gentech Laboratories?
Unlock access to Gentech Laboratories's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Novamox Vincom Pvt Ltd
Active
29 years 9 months Rajesh Gandhi, Chandrakant Gandhi and 1 more are mutual person
Antibiotic Stores Private Limited
Active 63 years 11 months Rajesh Gandhi and Chandrakant Gandhi are mutual person
Fusion Fiscal Services Ltd
Active 30 years 11 months Rajesh Gandhi and Chandrakant Gandhi are mutual person
Ethnic Holdings Pvt Ltd
Active 30 years 11 months Rajesh Gandhi and Chandrakant Gandhi are mutual person
Gentech Properties Private Limited
Active 8 years 4 months Chandrakant Gandhi and Manharlal Shah are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Kapole Co-Op Bank Ltd Creation Date: 20 Jun 2002 | ₹0.48 M | Open |
Indian Bank Creation Date: 17 Jun 1988 | ₹5.10 M | Open |
Indian Bank Creation Date: 20 Aug 1987 | ₹0.95 M | Open |
How Many Employees Work at Gentech Laboratories?
Unlock and access historical data on people associated with Gentech Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Gentech Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gentech Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
